Answers are grounded in this paper and cite their sources.
The number of people with heart failure is increasing rapidly worldwide. Despite preventive measures, optimal medical therapy, and cardiac transplantation, the overall morbidity and mortality of this syndrome remain high. Ventricular assist devices are well established as a treatment for heart failure and are increasingly used globally, both for destination therapy and as a bridge to cardiac transplantation. The management of these patients requires the training of a highly specialized team to ensure optimal outcomes. This article focuses on implementing a multidisciplinary team on the ventricular assist device, ensuring comprehensive care for implanted patients to mitigate potential complications early.
No takes yet. Share an insight, caveat, or question.
Amato et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: